Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecan.
<h4>Background</h4>Perfusion weighted imaging (PWI) can be used to measure key aspects of tumor vascularity in vivo and recent studies suggest that perfusion imaging may be useful in the early assessment of response to angiogenesis inhibitors. Aim of this work is to compare Parametric Re...
Saved in:
| Main Authors: | Domenico Aquino, Anna Luisa Di Stefano, Alessandro Scotti, Lucia Cuppini, Elena Anghileri, Gaetano Finocchiaro, Maria Grazia Bruzzone, Marica Eoli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0090535&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BEVACIZUMAB IN COMBINATION WITH IRINOTECAN IN THE TREATMENT OF RECURRENT GLIOBLASTOMAS
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01) -
MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives
by: Domenico Aquino, et al.
Published: (2017-01-01) -
Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcer
by: Jungić Saša, et al.
Published: (2017-01-01) -
Re-irradiation combined with bevacizumab in the treatment of glioblastoma recurrence
by: S. V. Belokon, et al.
Published: (2024-03-01) -
Effect of Gender on Coagulation Functions: A Study in Metastatic Colorectal Cancer Patients Treated with Bevacizumab, Irinotecan, 5-Fluorouracil, and Leucovorin
by: Cemil Bilir, et al.
Published: (2014-01-01)